• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Tengion Inc.

Tengion successor RegenMedTX raises $4m

August 6, 2015 By Brad Perriello

RegenMedTX, which acquired the assets of bankrupt organ regeneration technology company Tengion (NSDQ:TNGN) in March, said it raised more than $4 million from a syndicate of 27 unnamed investors. Winston-Salem, N.C.-based RegenMedTX is led by former Tengion CSO Tim Bertram and CTO Deepak Jain, the Winston-Salem Journal reported. Tengion, which pulled the plug in December 2014 after seeking but […]

Filed Under: Funding Roundup, Regenerative Medicine Tagged With: RegenMedTX, Tengion Inc.

New inversion rules are unlikely to scuttle Medtronic’s pending $43B merger with Covidien | The week in medtech M&A

October 1, 2014 By MassDevice Leave a Comment

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

September 24, 2014 by Brad Perriello

Filed Under: Mergers & Acquisitions, News Well Tagged With: Allergan, Covidien, Jefferies LLC, Pershing Square Capital Management, Tengion Inc., U.S. Treasury Dept., Valeant Pharmaceuticals

Tengion is on the auction block

September 29, 2014 By Alex Soule

Tengion, TNGN, Jefferies, organ regeneration, kidney

YYmeta

Tengion (NSDQ:TNGN) said it’s hired Jefferies to assess "all strategic alternatives," corporate shorthand for putting the Winston-Salem, N.C.-based company and its organ regeneration technology on the auction block.

Filed Under: Mergers & Acquisitions, News Well, Regenerative Medicine, Wall Street Beat Tagged With: Jefferies LLC, Tengion Inc.

Tengion’s Q2 losses widen

August 20, 2013 By Sony Salzman Leave a Comment

Tengion parses losses while ramping up spending

Tengion (NSDQ:TNGN) almost tripled its losses in the 2nd quarter, but raked in more than $30 million in investments for its human organ regeneration technology.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2013, Artificial Organs, Q2, Tengion Inc.

Tengion raises $74M for organ programs

August 7, 2013 By Brad Perriello Leave a Comment

Tengion raises $74M for organ programs

Tengion (NSDQ:TNGN) said it raised $74.3 million from 22 unnamed investors as it puts a pair of clinical programs through their paces.

The Winston-Salem, N.C.-based medical device company is developing the Neo-Kidney Augment and Neo-Urinary Conduit, human organs that are grown using a bioabsorbable scaffold and patients’ own cells.

Filed Under: Funding Roundup, News Well, Regenerative Medicine Tagged With: Tengion Inc.

Tengion soars on raising $34M in support of organ regeneration platform

July 2, 2013 By Arezu Sarvestani Leave a Comment

Tengion logo

North Carolina regenerative medicine company Tengion (NSDQ:TNGN) raised $33.6 million in support of clinical studies of its leading programs, the Neo-Kidney Augment and Neo-Urinary Conduit programs. TNGN shares jumped 15.3% to 68¢ around 12:40 p.m. today, up from an opening price of 64¢.

Filed Under: Funding Roundup, News Well, Regenerative Medicine Tagged With: Tengion Inc.

Tengion issues updates on clinical trial following patient deaths

October 26, 2012 By MassDevice staff Leave a Comment

Tengion logo

Tengion (NSDQ:TNGN) plans to complete enrollment its in Neo-Urinary Conduit clinical trial following the deaths of 2 of the 6 enrolled patients after deeming the deaths unrelated to the device or surgical procedure.

Filed Under: News Well Tagged With: Clinical Trials, Renal, Tengion Inc.

Diabetes: Medtronic’s Resolute stent performs well in non-diabetics, too | Wall Street Beat

May 25, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) touted new study results for its Resolute drug-eluting stents, the 1st with FDA indication for treatment of patients with diabetes.

Filed Under: Drug-Eluting Stents, Funding Roundup, News Well, Wall Street Beat Tagged With: Allscripts, Clinical Trials, Deals Roundup, Neurometrix, Tengion Inc., Uroplasty Inc.

Abbott wins FDA nod for next-gen cataract laser | Regulatory Roundup

April 20, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 Abbott gets FDA nod for advanced femtosecond laser for cataract surgery

Filed Under: 510(k), News Well Tagged With: Abbott, Bayer, Carestream Health Inc., Devicor Medical Products, Isansys, ITGI Medical Ltd., Neurometrix, NLT Spine, Regulatory Roundup, Revolutions Medical Corp., stjudemedical, Tengion Inc.

Bovie swings to 2011 black | Earnings Roundup

March 30, 2012 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

Bovie Medical swings to 2011 black

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Bovie Medical Corp., Cambridge Heart Inc., Daxor Corp., Dehaier Medical Systems Ltd., Derma Sciences Inc., Echo Therapeutics Inc., EDAP TMS SA, Guided Therapeutics Inc., Kips Bay Medical Inc., Lumenis Ltd., mazorrobotics, Nephros, Non-Invasive Monitoring Systems Inc., Patient Safety Technologies Inc., Q4, Response Biomedical Corp., SANUWAVE Health Inc., Stereotaxis, Tengion Inc., Vasomedical Inc., Young Innovations

White House defends Obamacare insurance mandate in Supreme Court brief | MassDevice.com On Call

January 9, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — In a Supreme Court briefing on Friday, the Obama administration defended its health care reform law, arguing that the Supreme Court would need to break with clear precedent in order to justify cutting down the insurance mandate.

The health care law requires most all Americans to purchase health insurance or pay a penalty, which the Justice Department defines as an unconstitutional tax. GOP lawmakers are urging the Supreme Court to strike down the entire Affordable Care Act if the individual mandate is deemed unconstitutional.

Filed Under: Healthcare Reform, Implants, Legal News, News Well, Robotics Tagged With: Hearing, Insurance, Tengion Inc., U.S. Justice Dept. (DOJ), U.S. Supreme Court

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS